Its role in modulation of adaptive immune responses, for example suppressing T cell-mediated immune responses, was originally identified in a murine model of cancer that Gr-1+ cells can inhibit T cell activation through CD3/CD28 co-stimulation (51, 52). Here, CD28 is linked to cancer.